FAM Tag Size Separation-Based Capture-Systematic Evolution of Ligands by Exponential Enrichment for Sterigmatocystin-Binding Aptamers with High Specificity.
Mengyao ZhengJin YeHongmei LiuYu WuYakun ShiYanli XieSongxue WangPublished in: Analytical chemistry (2024)
Sterigmatocystin (ST) is a known toxin whose aptamer has rarely been reported because ST is a water-insoluble small-molecule target with few active sites, leading to difficulty in obtaining its aptamer using traditional target fixation screening methods. To obtain aptamer for ST, we incorporated FAM tag size separation into the capture-systematic evolution of ligands by exponential enrichment and combined it with molecular activation for aptamer screening. The screening process was monitored using a quantitative polymerase chain reaction fluorescence amplification curve and recovery of negative-, counter-, and positive-selected ssDNA. The affinity and specificity of the aptamer were verified by constructing an aptamer-affinity column, and the binding sites were predicted using molecular docking simulations. The results showed that the K d value of the H Seq02 aptamer was 25.3 nM. The aptamer-affinity column based on 2.3 nmol of H Seq02 exhibited a capacity of about 80 ng, demonstrating better specificity than commercially available antibody affinity columns. Molecular simulation docking predicted the binding sites for H Seq02 and ST, further explaining the improved specificity. In addition, circular dichroism and isothermal titration calorimetry were used to verify the interaction between the aptamer and target ST. This study lays the foundation for the development of a new ST detection method.
Keyphrases
- gold nanoparticles
- sensitive detection
- label free
- magnetic nanoparticles
- molecular docking
- small molecule
- liquid chromatography
- genome wide
- single cell
- molecular dynamics simulations
- molecular dynamics
- high resolution
- gene expression
- transcription factor
- minimally invasive
- loop mediated isothermal amplification
- photodynamic therapy
- structural basis
- nucleic acid
- dna methylation